Skip to main content
. 2015 Nov 13;6:270. doi: 10.3389/fphar.2015.00270

TABLE 1.

Targets for reversible cardiac protein phosphorylation.

Protein Reported kinase activity Phosphorylation site Reported phosphatase activity Reference
Aurora B n.d. n.d. PP1 Murnion et al. (2001)
CaV1.2 α CaMKII Ser1512,
Ser1570
PP1
PP2A
PP2B
Davare et al. (2000), Kamp and Hell (2000), Chen et al. (2002), Yang et al. (2005, 2007), Hall et al. (2006), Hulme et al. (2006), Lee et al. (2006), Sun et al. (2006), Lemke et al. (2008), Tandan et al. (2009), Blaich et al. (2010), Xu et al. (2010), Brandmayr et al. (2012), Shi et al. (2012), Minobe et al. (2014)
PKA Ser1574,
Ser1866,
Ser1928
PP1
PP2A
PKC Ser1928 PP1 (major)
PP2A (minor)
PKG Ser1928
Akt/PKB n.d. n.d.
CaV1.2 β PKC Ser496 PP1
PP2A
Gerhardstein et al. (1999), Grueter et al. (2006), Yang et al. (2007), Abiria and Colbran (2010)
CaMKII Thr498
PKA Ser458, Ser478, Ser479
PKG Ser496
cMyBP-C PKAPKC Ser282
Ser273 (HF)
Ser302 (HF)
PP1
PP2A
Mohamed et al. (1998), Florea et al. (2012), Heijman et al. (2013)
Cold shock domain protein ACSDA Bcr-Abl kinasePI3K/AktRibosomal S6 kinase (RSK) Ser134 PP1 Sears et al. (2010), Chiang et al. (2015)
Connexin 43 PKC Ser368 PP1
PP2A
Ai and Pogwizd (2005), Ai et al. (2011)
PKA Ser262
CREB PKA
PKC
Casein kinase II
CaMKIIP90 (RSK)
Ser133 PP1
PP2A
Montminy et al. (1990), Miller et al. (1998), Li et al. (2006)
eIF2α n.d. n.d. PP1 Ceulemans and Bollen (2004)
FAK n.d. n.d. PP1α in vitro Yamakita et al. (1999)
Glycogen synthase kinase PKA Ser67
Ser48
PP1
PP2A
Woodgett and Cohen (1984), Walker et al. (2000)
HDAC4 CKIP
PKA
CaMKII
Ser246
Ser467
Ser632
PP2A Zhang et al. (2002), Backs et al. (2006)
Histone3 CaMKII Thr3
Ser28
Ser10
PP1 Ceulemans and Bollen (2004), Awad et al. (2013)
I-1 PKA Thr35 PP2A
PP2B
El-Armouche et al. (2006a), Wittkopper et al. (2010a)
PKCα Ser67
Na+/K+ ATPase PKC Ser18 PP2A Palmer et al. (1991), Feschenko and Sweadner (1997)
NaV1.5 CaMKII Ser571
Thr594
Ser516
n.d. Murray et al. (1997), Zhou et al. (2000), Baba et al. (2004), Wagner et al. (2006), Hund et al. (2010), Ashpole et al. (2012), Toischer et al. (2013)
PKA Ser525
Ser528
PKC n.d.
NCX1 PKA (in vitro), PKC Thr731 (in vitro) PP1
PP2A
PP2B
Palmer et al. (1991), Schulze et al. (2003), Wei et al. (2003, 2007), Shigekawa et al. (2007), Zhang and Hancox (2009), Wanichawan et al. 2011
Neurabin P70S6 kinase n.d. PP1 McAvoy et al. (1999), Sakisaka et al. (1999), Oliver et al. (2002)
PKA Ser461
NFATs PKA
GSK3β
DYRK1/2
CK1
MEKK1
JNK
P38MAPK
multiple PP2B Beals et al. (1997), Chow et al. (1997, 2000), Zhu et al. (1998), Chow and Davis (2000), Gomez del Arco et al. (2000), Sheridan et al. (2002), Yang et al. (2002), Okamura et al. (2004), Gwack et al. 2006
PDE4D3 PKA Ser13
Ser54
PP1
PP2A
Egloff et al. (1997), Carlisle Michel et al. (2004), Dodge-Kafka et al. (2006), De Arcangelis et al. 2008
ERK5 Ser579
PDE5A n.d. n.d. PP1 Chiang et al. (2015)
Phospholemman PKA Ser68 PP1 Palmer et al. (1991), El-Armouche et al. (2011)
PKC Ser63
Ser68
PLB PKA Ser16 PP1
PP2A
MacDougall et al. (1991), Luo et al. (1994), Jackson and Colyer (1996), Chu and Kranias (2002)
CaMKII Ser17
PMCA PKA
PKC
n.d. PP1
PP2A
Zylinska et al. (1998), Zylinska and Soszynski (2000)
P70S6 Kinase n.d. n.d. PP1
PP2A
Bettoun et al. (2002)
Retinoblastoma protein (Rb) CDK Thr320 PP1 Liu et al. (1999), Ceulemans and Bollen (2004)
RyR2 PKA Ser2808
Ser2030
PP1
PP2A
PP2B
Marx et al. (2000), Pare et al. (2005), Xiao et al. (2005, 2006), Meng et al. (2007), Liu et al. (2011, 2014), Zhang et al. (2012)
CaMKII Ser2814
SERCA2a CaMKII Ser38
(Ser167, Ser531 → in vitro)
n.d. Brandl et al. (1986), Narayanan and Xu (1997)
SF2/ASF PKA n.d. PP1 Gu et al. (2011), Huang et al. (2014)
Tn-inhibitor (TnI) PKA Ser23
Ser24
PP1
PP2A
Cole and Perry (1975)
T-type calcium channel (Cav3.2) PKA Ser1107
Thr2214
Ser1144
n.d. Chemin et al. (2007), Hu et al. (2009)
Vitamin D receptor P70S6PI-3
kinaseB/Akt
n.d. PP1
PP2A
Bettoun et al. (2002)
Yotiao/KCNQ1 PKA Ser27 PP1 Westphal et al. (1999), Marx et al. (2002), Terrenoire et al. (2009)

This table lists currently known substrates, which PK-mediated phosphorylation is counteracted by PP1, PP2A, or/and PP2B.